Sharda Mukul, Sharma Saujas, Raikar Shaunak, Verhagen Nathaniel, Wagle Janavi, Mathur Ritisha, Gowda Saathvik, Kommu Sharath, Prasad Rupesh, Bhandari Sanjay, Jha Pinky
Internal Medicine, Medical College of Wisconsin, Milwaukee, USA.
Neuroscience, University of Michigan, Ann Arbor, USA.
Cureus. 2025 May 24;17(5):e84761. doi: 10.7759/cureus.84761. eCollection 2025 May.
Hospital readmissions contribute significantly to healthcare costs. While traditional regression models for predicting 30-day readmission risk offer modest accuracy, machine learning (ML) presents an opportunity to capture complex relationships in healthcare data, potentially enhancing predictions. This review assesses the role of ML in predicting 30-day readmissions for general internal medicine admissions in the U.S. Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, a literature search of PubMed (2014-2023) was conducted using the keywords "artificial intelligence," "machine learning," and "readmission." The review focused on ML models predicting readmissions in general internal medicine patients in the U.S. Nine studies were reviewed, covering conditions like acute myocardial infarction (AMI), heart failure (HF), pneumonia (PNA), chronic obstructive pulmonary disease (COPD), and other general internal medicine cases. ML models such as artificial neural networks (ANN), random forests (RF), gradient boosting, logistic regression, and natural language processing (NLP) were used. ANN and RF models outperformed traditional regression methods, while NLP-based approaches showed limited success. Subgroup modeling provided marginal improvements in predictive accuracy. In conclusion, ML offers significant potential for improving 30-day readmission predictions by overcoming the limitations of traditional models. ANN and RF are particularly effective in predicting readmissions in general internal medicine. To advance predictive capabilities, future research should refine NLP, subgroup modeling, and focus on model generalizability, integration of diverse data sources, and the development of explainable AI for clinical adoption. Addressing these challenges could transform healthcare delivery, improve patient outcomes, and reduce costs.
医院再入院显著增加了医疗成本。虽然用于预测30天再入院风险的传统回归模型准确性一般,但机器学习(ML)为捕捉医疗数据中的复杂关系提供了机会,有可能提高预测能力。本综述评估了ML在美国普通内科住院患者30天再入院预测中的作用。按照系统评价和Meta分析的首选报告项目(PRISMA)指南,使用关键词“人工智能”、“机器学习”和“再入院”对PubMed(2014 - 2023年)进行了文献检索。该综述聚焦于预测美国普通内科患者再入院的ML模型。共审查了9项研究,涵盖急性心肌梗死(AMI)、心力衰竭(HF)、肺炎(PNA)、慢性阻塞性肺疾病(COPD)等疾病以及其他普通内科病例。使用了人工神经网络(ANN)、随机森林(RF)、梯度提升、逻辑回归和自然语言处理(NLP)等ML模型。ANN和RF模型优于传统回归方法,而基于NLP的方法成效有限。亚组建模在预测准确性上有小幅提升。总之,ML通过克服传统模型的局限性,在改善30天再入院预测方面具有巨大潜力。ANN和RF在预测普通内科再入院方面特别有效。为提高预测能力,未来研究应完善NLP、亚组建模,并关注模型的通用性、不同数据源的整合以及可解释人工智能的开发以用于临床应用。应对这些挑战可以改变医疗服务的提供方式,改善患者预后并降低成本。